Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and efficacy of contizolamide in acute pancreatitis with gram-positive infection
ChiCTR2300071006Phase 4Not yet recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of contizolamide in acute pancreatitis (AP) and Gram-positive bacterial infection, sponsored by Sir Run-Run Shaw Hospital. Primary endpoints: Clinical cure rate and Bacterial clearance rate. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
contizolamide
03
Conditions
acute pancreatitis (AP)Gram-positive bacterial infection
Beyond the preview
Go deeper on ChiCTR2300071006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071006.